Theriva Biologics, Inc (MD)
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2016
- $521.01K
- $521,014under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 1
- with positive net obligations
- Latest action
- Jun 26, 2023
- SAM.gov registration
- Active
- Registration expiration date May 8, 2027
Registration
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Business start date
- Dec 23, 2008 (17 years)
- Location
- Rockville, MD
- State of incorporation
- Nevada
- Purpose of registration
- All Awards
- Website
- therivabiologics.com
† FY2026 obligations (provisional; DoD awards signed after Jul 27, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI UGJCK56BHQU7. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2016. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2016: $521,014
Total across 1 fiscal year: $521,014
Top awarding agencies
- Department of Health and Human Services$521,014, 100%
Top awarding sub-agencies
- Centers for Disease Control and Prevention$521,014, 100%
Top NAICS by obligations
- 541711Research and development in biotechnology$521,014, 100%
Top product and service codes by obligations
- AN11R&d- medical: biomedical (basic research)$521,014, 100%
Capabilities
NAICS codes
Small: small business for that NAICS, self-certified in SAM.gov registration.
SBA certifications
No certification in the SBA profile data.
Business types self-reported in SAM.gov registration:
- Self Certified Small Disadvantaged Business
Federal Capability Statement
Synthetic Biologics, Inc. (NYSE American: SYN) is a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients. The Company's lead candidates poised for Phase 3 development are: (1) SYN-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C. difficile infection (CDI), overgrowth of pathogenic organisms and the emergence of antimicrobial resistance (AMR), and (2) SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C). The Company’s preclinical pursuits include an oral formulation of the enzyme intestinal alkaline phosphatase (IAP) to treat both local GI and systemic diseases
Capabilities & Services
Contracts
Latest awards and orders
- HHSD200201691935CDefinitive contractDepartment of Health and Human ServicesCenters for Disease Control and PreventionLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for Theriva Biologics, Inc lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
9605 Medical Center Dr Ste 270
Rockville, MD, 20850
USA
Mailing Address
9605 Medical Center Dr Ste 270
Rockville, MD, 20850
USA
Government Business Contact
Timothy J Swope
Vice President of Non-Clinical Affairs
9605 Medical Center Drive
Suite 270
Olney, MD, 20832
USA
Electronic Business Contact
Timothy J Swope
Vice President Controller
9605 Medical Center Dr Ste 270
Rockville, MD, 20850
USA
Additional Details
As of . Source: SAM.gov Entity Registration.
Theriva Biologics, Inc has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires May 8, 2027.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Not registered for disaster relief
Bonding Information
No bonding information provided
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation
Congressional District
Other contractors in Maryland with primary NAICS 541714
- Axle Informatics, LLCNorth Bethesda, MD
- Emergent Product Development Gaithersburg Inc.Gaithersburg, MD
- Battelle National Biodefense Institute, LLCFort Detrick, MD
- Public Health Vaccines LLCElkridge, MD
- Advanced Bioscience Laboratories, Inc.Potomac, MD
- Cellphire, Inc.Rockville, MD